Sign In
Buy EVR
$340.09
-6.97 (-2.01%)
At Close: Jun 03, 2026
Prime Medicine to Present at 8th Annual Evercore Healthcare Conference
08:00am, Tuesday, 25'th Nov 2025
CAMBRIDGE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapi
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
07:00am, Tuesday, 25'th Nov 2025
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disord
Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
07:00am, Tuesday, 25'th Nov 2025
CAMBRIDGE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases b
C4 Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
07:00am, Tuesday, 25'th Nov 2025
WATERTOWN, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science,
iBio to Participate in the 8th Annual Evercore Healthcare Conference
04:15pm, Monday, 24'th Nov 2025
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the 8th Annual Evercore Heal
Contineum Therapeutics to Attend the 8th Annual Evercore Healthcare Conference
04:05pm, Monday, 24'th Nov 2025
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of
Rani Therapeutics to Participate in the Evercore Healthcare Conference
04:05pm, Monday, 24'th Nov 2025
SAN JOSE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the ora
Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference
04:05pm, Monday, 24'th Nov 2025
BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ funct
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
09:00am, Monday, 24'th Nov 2025
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical compan
Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference
07:00am, Monday, 24'th Nov 2025
NEW YORK and WALTHAM, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to t
TEL AVIV, Israel, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and other members of execu
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
04:30pm, Friday, 21'st Nov 2025
SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,
Butterfly Network to Participate at the 8th Annual Evercore Healthcare Conference
08:05am, Friday, 21'st Nov 2025
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound
Omada Health to Participate in Evercore Healthcare Conference
09:05am, Thursday, 20'th Nov 2025
SAN FRANCISCO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 8
4DMT to Participate in 8th Annual Evercore Healthcare Conference
08:00am, Thursday, 20'th Nov 2025
EMERYVILLE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted t
